AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.
10.14701/kjhbps.2014.18.1.33
- Author:
Chang Young KIM
1
;
Sung Hwan LEE
;
Hyae Min JEON
;
Hyun Ki KIM
;
Chang Moo KANG
;
Woo Jung LEE
Author Information
1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. cmkang@yuhs.ac
- Publication Type:Case Report
- Keywords:
Alpha-fetoprotein;
Acinar cell carcinoma;
Pancreatectomy;
Gastric cancer
- MeSH:
Acinar Cells*;
Adenosine;
alpha-Fetoproteins;
Carcinoma;
Carcinoma, Acinar Cell*;
Chemotherapy, Adjuvant;
Cisplatin;
Drug Therapy;
Female;
Gastrectomy*;
Humans;
Neck;
Pancreas;
Pancreatectomy;
Pancreaticoduodenectomy*;
Pneumonia;
Stomach Neoplasms*
- From:Korean Journal of Hepato-Biliary-Pancreatic Surgery
2014;18(1):33-37
- CountryRepublic of Korea
- Language:English
-
Abstract:
We report a case of alpha-fetoprotein (AFP)-producing acinar cell carcinoma (ACC) of the pancreas. The tumor was diagnosed in a 72 yearold female after radical subtotal gastrectomy (Billroth I) due to early gastric cancer six months before. The initial serum AFP levels were increased to 2,254.1 IU/ml and preoperative imaging studies showed a mass with approximately 2.5 cm in diameter near the neck of the pancreas. A pancreaticoduodenectomy was performed. The pathologic examination revealed an ill-defined lobulating tumor confined to the pancreas (T1 stage). Immunohistochemical study showed that the tumor cells expressed AFP. The Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) suggested that cisplatin would be more desirable than gemcitabine in AFP-producing ACC of the pancreas as an adjuvant chemotherapy. However, the adjuvant chemotherapy was not performed due to the early pathological stage. The patient died from carcinomatosis and pneumonia. Even if the tumor was on a relatively early stage, an adjuvant treatment should be considered ACC.
